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1. Introduction 
The activity of the enzyme, ornithine decarboxy- 
lase (EC 4.1.1.17) which is rate limiting in the syn- 
thesis of the polyamines, putrescine, spermidine and 
spermine, is rapidly stimulated by conditions which 
promote growth, and declines quickly when growth 
is inhibited [1,2]. Since cycloheximide and actino- 
mycin D block this stimulation, and frequently cause 
a rapid loss in existing activity, it is thought hat the 
mechanism of control of this apparently abile enzyme 
is through the regulation of its synthesis and degrada- 
tion [3-6].  Recently, however, Mitchell and Sedory 
[7] presented evidence suggesting that the rapid 
fluctuations in the ornithine decarboxylase activity 
of Physarum, which had been exposed to cyclo- 
heximide, were in a large part due to variations in the 
ability of this enzyme to be activated by its coenzyme, 
pyridoxal 5'-phosphate (PLP). Regulation by such an 
enzyme modification is in agreement with the accu- 
mulating evidence for at least partial control of this 
enzyme by post-transcriptional mechanisms [8-11 ]. 
In this report we present evidence for the existence 
of multiple ornithine decarboxylase forms in Physarum 
which are involved in the regulation of this enzyme's 
activity. 
2. Materials and methods 
2.1. Chemicals 
Pyridoxal 5'-phosphate, L-ornithine, blue dextran 
and cycloheximide were purchased from Sigma 
Chemical Co.; Sephadex G-200 (40-120/li) from 
Pharmacia Fine Chemicals Inc.; and DL- [ 1Jac] orni- 
thine • HC1 (29 Ci/mole) from Amersham/Searle 
Corporation. 
2.2. Culture techniques 
Cultures ofP. polycephalum were maintained and 
sampled as described earlier [3]. 
2.3. Preparation of  enzyme xtracts 
Frozen tissue pellets containing about 3-5 mg of 
protein were suspended in 3 ml of ice-cold 0.05 M 
borate buffer (pH 7.8), containing 0.5 mM dithio- 
threitol and 0.2 mM EDTA, disrupted by sonicating 
for 30 sec and assayed immediately. 
2.4. Ornithine decarboxylase assay 
Enzyme activity was determined by measuring the 
liberation of 14CO2 from DI., [ 1-14C] ornithine as 
detailed earlier [3], except hyamine hydroxide was 
used to absorb the 14CO2 which was counted in a 
toluene-based scintillation fluid. The incubation 
mixtures are described in the figure legends. 
2.5. Sephadex G-200 column chromatography 
Enzyme extracts were prepared for chromato- 
graphy by sonicating the frozen pellets in 0.05 M 
borate buffer (pH 7.8), containing 1.0 mM dithio- 
threitol, 0.5 mM EDTA and 2/~M PLP. One ml of 
this extract was mixed with 2 mg blue dextran, 
applied to a 40 X 1.6 cm Pharacia column containing 
Sephadex G-200 which had been pre-equilibrated 
with this buffer, and eluted with the same buffer at 
4.5 ml/h. Estimation of mol. wts were made accord- 
ing to the techniques of Andrews [ 12]. All proce- 
dures performed at 4°C. 
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3. Results 
3.1. Cycloheximide-induced variations in ornithine 
decarboxylase activity 
The lower curve in fig. 1 illustrates the very rapid 
initial increase and eventual loss of ornithine decar- 
boxylase activity in Physarum exposed to cyclo- 
heximide. However, when the same enzyme prepara- 
tions were assayed in the presence of an unphysiologi- 
cally high coenzyme level, 200/aM PLP, the variations 
in activity were greatly reduced (upper curve, fig. 1). 
3.2. Variable coenzyme activation of cycloheximide 
treated samples 
The disagreement between the estimation of 
enzyme stability by assays at high and low P IP  levels 
was further investigated by assaying these enzyme 
fractions at PLP concentrations increasing from 0.2 
to 500/aM PLP. When this data was graphed as a 
double reciprocal plot, it became obvious that this 
enzyme did not demonstrate normal Michaelis- 
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Fig.1. Decay in ornithine decarboxylase activity in micro- 
plasmodia exposed to 25 ~g/ml of cycloheximide. Inhibitor 
was added to a shake-flask culture of Physarum microplas- 
modia at time 0 and subsequently culture aliquots were 
extracted, quick-frozen in liquid nitrogen and assayed as 
described in Materials and methods. Assay mix contained 
100 ~ul of enzyme xtract and 1.9 ml of 0.05 M borate buffer 
(pH 7.8), 0.5 mM dithiothreitol, 0.2 mM EDTA, 0.10 mM 
L-ornithine (0.10 ~*Ci) and either 1 (A) or 200 (e) M PLP. 
Menten saturation kinetics throughout the entire 
coenzyme range (fig.2). At low coenzyme levels 
(0.2-1.0/aM PLP) all time points extrapolated to 
about the same K M for PLP, 0.46/aM. At higher PLP 
levels (1.0-200/aM PLP), however, all the curves bent 
down sharply to approach about the same maximum 
velocity at saturating PLP levels. Such reciprocal 
plots, concave from below, have been reported pre- 
viously in association with ornithine decarboxylase 
activity at high coenzyme concentrations [ 13,14]. 
One interpretation of such a complex coenzyme 
activation pattern is that we are observing two or 
more simultaneous reactions, perhaps involving 
distinct enzymes, which may be separated and iden- 
tified by their relative affinity for coenzyme. There- 
fore, small aliquots of crude enzyme were applied to 
Sephadex G-200 columns equilibrated with borate 
buffer, and the resulting fractions were assayed at 
both low (1.0/aM) and high (200/aM) PLP levels. As 
seen in fig.3, all the enzyme activity stimulated by 
1.0/aM PLP eluted in a peak which corresponded to
an approximate molecular weight of 160 000 daltons. 
The use of 200/aM coenzyme in the assays not only 
increased the activity in the 160 000 mol. wt. peak 
(peak II) but also stimulated previously unobserved 
ornithine decarboxylase activity in fractions very 
close to the void volume (peak I). Occasionally a 
small peak of activity was also observed at about 
mol. wt. 80 000 (peak III). No activity was observed 
above boiled enzyme controls when fractions were 
assayed without any added coenzyme, thus the 
activation of peak II by 1/aM PLP must be the expres- 
sion of enzyme with a low K M for the coenzyme. 
This enzyme form may therefore represent the active 
state of this enzyme in the low P IP  environment 
found in vivo. The decarboxylation f ornithine in 
peaks I and III, stimulated only by very high coen- 
zyme levels, then may indicate either inactive forms 
of this enzyme, or other enzymes capable of releas- 
ing the carboxyl group from ornithine under these 
saturating coenzyme conditions. 
3.3. Cycloheximide-induced interconversion f 
enzyme forms 
Repeated separations were made, on identical 
Sephadex G 200 columns, of samples taken at various 
times after cycloheximide addition (rigA). Although 
the total activity measured in the presence of 200/aM 
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Fig.2. PLP activation of ornithine decarboxylase following cycloheximide inhibition of protein synthesis. Aliquots were extracted 
and assayed, as described in the legend to fig.l, 0 (e) 5 (X) and 100 (A) minutes after the addition of cycloheximide, using the 
various coenzyme levels indicated. 
2.0 
J¢ 
o" 
1.5 
i¢ 
I.O 
I- 
I - -  
w 
0.5  
N 
Z 
W 
0 
0 5 I0 15 20 25 50 55 
FRACTION NUMBER 
Fig. 3. Multiple peaks of ornithine decarboxylase activity 
eluted from a 40 × 1.6 cm Sephadex G-200 column. A 
sample of microplasmodia were sonified in column buffer 
and 1 ml aliquots fractionated on Sephadex G-200 as 
described in Materials and methods. Fractions (0.8 ml) 
following the blue dextran peak were collected, and 0.1 ml 
aliquots assayed, as in the legend for fig. 1, using either 1 (A) 
or 200 (e) taM PLP. 
PLP varied only slightly during this cycloheximide 
inhibition period (fig. 1), the distribution of this 
activity in the column eluant changed considerably. 
In all cases the recovery off these columns was 
between 90 and 100% of the activity applied. Activity 
stimulated by 1/aM PLP did not shift from the peak 
II position but rather increased and decreased in
direct proportion to the height of the same peak when 
measured in the presence of 200/aM PLP. 
Within 5 min of cycloheximide addition almost all 
the activity in peak I, detected using 200/aM PLP, 
was shifted to peak II, the lowK M peak. After 10 min, 
low K M activity was progressively lost with a simul- 
taneous increase in peak I, the higher mol. wt. unit, 
until, after 90 min, more activity was in peak I than 
II. This interconvertibility between these peaks of 
activity, along with the kinetic support for two such 
reactions in crude enzyme preparations, suggested 
that these may be two states of the same enzyme, 
i.e. active and inactive, with different affinities for 
coenzyme, rather than two separate nzymes. 
3.4. Coenzyme-induced changes in enzyme size in vitro 
Since the inactive forms of this enzyme were 
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Fig.4. The interconversion f forms I and II following cyclo- 
heximide addition. Cultures were treated with cycloheximide 
and samples extracted as described in the legend to rigA. 
Using the same column on consecutive days, separations 
were made as described in the legend to fig.3, of enzyme 
extracted at various times after the addition of cycloheximide. 
Coenzyme levels and graph symbols are as described in the 
legend for fig.3. 
either much larger or smaller than the active 160 000 
dalton form it was of interest o know whether 
activation was merely determined by a certain degree 
of polymerization of inactive nzyme subunits, or if 
it involved a more complex alteration or addition to 
the basic enzyme protein. The former mechanism 
was suggested by the.observation that the peak I
enzyme form, resulting from treatment with cyclo- 
heximide for 90 min, could be completely converted 
to the peak II form when enzyme preparation and 
column separation were performed in buffer con- 
taining 200/aM PLP. However, an identical sample, 
dialyzed first withhigh PLP for 6 h, and subsequently 
dialyzed against he normal, low PLP buffer for 12 h 
showed both peak I and II forms when separated on a 
column containing low PLP buffer. Peak II enzyme, 
resulting from 5 min exposure to cycloheximide, did 
not show any such reversion to form I by similar 
treatment. Thus, unlike the in vitro activation of this 
enzyme by high PLP levels, the activation of this 
enzyme to produce form II in vivo must involve a 
modification which stabilizes this form. 
4. Discussion 
The interconversion f forms I and II in vitro (in 
response to coenzyme l vel changes) and in vivo (in 
response to cycloheximide treatment) is quite similar 
to the variations found in the multiple form patterns 
of rat liver tyrosine aminotransferase, another pyri- 
doxal enzyme [15-19]. In that enzyme it is believed 
that the multiple forms represent post-translational 
modifications associated with enzyme activation, 
hormonal response, and eventual degradation [17]. 
The interconversion f the Physarum ornithine decar- 
boxylase forms, which also appears to involve a post- 
translational modification, allows the regulation of 
form II, and since this form has the greatest affinity 
for coenzyme, nzyme activity. Thus the activity 
fluctuations reported previously [7] in response to 
cycloheximide, were due to this interconversion 
between the low K M (active) and high K M (inactive) 
enzyme forms, which produced adramatic variation 
in the overall K M for PLP when measured at inter- 
mediate coenzyme l vels. 
The tool. wt. of the peak III form is approx. 
80 000, or about one half that of peak II, suggesting 
that the latter may be a dimer of the peak III enzyme 
form. This relationship issimilar to that found in the 
pyridoxal enzymes, L-serine dehydratase [20] and 
aspartate ~3-decarboxylase [21]. While simple dissocia- 
tion may account for the reversible conversion of 
form I to II by high PLP in vitro, the in vivo conversion 
is more stable and therefore probably involves a 
change in enzyme protein which stabilizes this partic- 
ular size unit. The activation and inactivation of 
mammalian ornithine decarboxylase bymonomeric 
and dimeric form conversion was initially suggested 
by Jffnne and Williams-Ashman i  1970 [22], how- 
ever until now there has been no evidence to sub- 
stantiate the existence of such interconverting states 
in vivo. The efficiency and sensitivity of post-transla- 
tional enzyme modification make this an attractive 
mode of activity regulation which would allow 
extremely rapid fluctuations in activity, which are 
characteristic of this enzyme, without he necessity 
for an abnormally short protein half-life. 
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